Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Site‐specific Bioconjugation and Convergent Click Chemistry Enhances Antibody–Chromophore Conjugate Binding Efficiency

Title: Site‐specific Bioconjugation and Convergent Click Chemistry Enhances Antibody–Chromophore Conjugate Binding Efficiency
Authors: Sadiki, Amissi; Kercher, Eric M.; Lu, Haibin; Lang, Ryan T.; Spring, Bryan Q.; Zhou, Zhaohui Sunny
Contributors: Richard and Susan Smith Family Foundation; National Institutes of Health
Source: Photochemistry and Photobiology ; volume 96, issue 3, page 596-603 ; ISSN 0031-8655 1751-1097
Publisher Information: Wiley
Publication Year: 2020
Collection: Wiley Online Library (Open Access Articles via Crossref)
Description: Photosensitizer (PS)–antibody conjugates (photoimmunoconjugates, PICs) enable cancer cell‐targeted photodynamic therapy (PDT). Nonspecific chemical bioconjugation is widely used to synthesize PICs but gives rise to several shortcomings. The conjugates are heterogeneous, and the process is not easily reproducible. Moreover, modifications at or near the binding sites alter both binding affinity and specificity. To overcome these limitations, we introduce convergent assembly of PICs via a chemo‐enzymatic site‐specific approach. First, an antibody is conjugated to a clickable handle via site‐specific modification of glutamine (Gln) residues catalyzed by transglutaminase (TGase, EC 2.3.2.13). Second, the modified antibody intermediate is conjugated to a compatible chromophore via click chemistry. Utilizing cetuximab, we compared this site‐specific conjugation protocol to the nonspecific chemical acylation of amines using N‐hydroxysuccinimide (NHS) chemistry. Both the heavy and light chains were modified via the chemical route, whereas, only a glutamine 295 in the heavy chain was modified via chemo‐enzymatic conjugation. Furthermore, a 2.3‐fold increase in the number of bound antibodies per cell was observed for the site‐specific compared with nonspecific method, suggesting that multiple stochastic sites of modification perturb the antibody–antigen binding. Altogether, site‐specific bioconjugation leads to homogenous, reproducible and well‐defined PICs, conferring higher binding efficiency and probability of clinical success.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1111/php.13231
Availability: https://doi.org/10.1111/php.13231; https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fphp.13231; https://onlinelibrary.wiley.com/doi/pdf/10.1111/php.13231; https://onlinelibrary.wiley.com/doi/full-xml/10.1111/php.13231
Rights: http://onlinelibrary.wiley.com/termsAndConditions#vor
Accession Number: edsbas.62700055
Database: BASE